MEPs to debate access to medicines
Concerns that patients may be deprived of innovative medicines due to their cost will be back on Parliament’s agenda in a debate with Latvian Secretary of State for European Affairs Kalniņa-Lukaševica and Commissionner Stylianides this evening. The high prices of new treatments for diseases such as Hepatitis C recently prompted MEPs and certain EU member states to call for EU-wide measures to help patients to access affordable and innovative therapies.
This plenary debate follows another last September, which was by a question tabled for an oral reply. In it, MEPs highlighted the need for more transparency on pharmaceutical pricing, particularly in view of the budgetary pressures on national health systems.
Debate: Wednesday, 11 February
Procedure: Council and Commission statements followed by debate (without resolution)
#medicines